(Q36897629)

16 August 2017

Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature (English)

1 reference

16 August 2017

Susana Murteira

1

1 reference

16 August 2017

Zied Ghezaiel

series ordinal

2

1 reference

16 August 2017

Slim Karray

series ordinal

3

1 reference

16 August 2017

Michel Lamure

series ordinal

4

1 reference

16 August 2017

6 August 2013

1 reference

Journal of market access & health policy

16 August 2017

1 reference

16 August 2017

1

1 reference

Ariadne's ChemEffect and Pathway Studio knowledge base

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

Industrial perspective of gastroretentive drug delivery systems: physicochemical, biopharmaceutical, technological and regulatory consideration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

Drug repositioning for personalized medicine.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

Discovery and preclinical validation of drug indications using compendia of public gene expression data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

Drug repositioning: re-investigating existing drugs for new therapeutic indications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

Bromocriptine: old drug, new formulation and new indication

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

Antidepressant reformulations: who uses them, and what are the benefits?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

The value of drug repositioning in the current pharmaceutical market

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

The prince and the pauper. A tale of anticancer targeted agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

"One pill, once daily": what clinicians need to know about Atriplatrade mark

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

Valproate as a mainstay of therapy for pediatric epilepsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

Putting chirality to work: the strategy of chiral switches

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

PROMISCUOUS: a database for network-based drug-repositioning

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4865745

Repurposing Strategies for Therapeutics

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.3402%2FJMAHP.V1I0.21131

First-year treatment patterns among new initiators of topical prostaglandin analogs

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3402%2FJMAHP.V1I0.21131

Economic analysis of Neoral in de novo renal transplant patients in Canada

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27226826

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Should dabigatran replace warfarin for stroke prevention in AF?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27226826

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3402/JMAHP.V1I0.21131

1 reference

16 August 2017

1 reference

16 August 2017

1 reference